Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells

NCT03435796 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT03435796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03435796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells
Lead sponsor
Celgene
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 19, 2018
Completion date
May 29, 2043
Enrollment
1,541 (estimated)
Sites
222

Conditions

As the registry lists them; a condition with its own page is linked.

neoplasms